1M6MYTD1A5AMAX
Cargando cotizaciones...
Previsión
| Comprar |
2 |
| Mantener |
0 |
| Vender |
0 |
Noticias Ir al feed de noticias
iSpecimen settles dispute with WestPark Capital by paying $97,500
iSpecimen reached a settlement agreement with WestPark Capital and will pay $97,500 to resolve all claims arising from prior investment banking engagements and an arbitration. WestPark had originally sought $269,999.91 plus interest and costs; the settlement is not an admission of liability. iSpecimen expects to record the payment as an expense in the quarter ended September 30, 2026. The company also reported the closing of a $2.5 million private placement with E.F. Hutton as placement agent. » Más en de.investing.com
Datos financieros de la empresa
| (EUR) | jun 2026 | |
|---|---|---|
| Ingresos | 133,13 mil | 78,00 % |
| Beneficio bruto | -116,37 mil | 151,00 % |
| Beneficio neto | -1,19 M | 34,40 % |
| EBITDA | -1,02 M | 95,21 % |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 191,84 mil € |
Número de acciones | 138,86 mil |
Máximo/mínimo de 52 semanas | 109,83 € - 1,21 € |
| Dividendos | No |
Beta | 1,64 |
Ratio P/E | -0,03 |
Ratio PEG | 0,00 |
Ratio P/B | 1,28 |
Ratio P/S | 0,48 |
Perfil de la empresa
| Nombre | iSpecimen Inc |
| CEO | Katharyn Field |
| Empleados | 7 |
Descubrir activos
Los accionistas de iSpecimen Inc también invierten en los siguientes activos






